InterOcean Capital Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$599K Sell
8,179
-484
-6% -$37.2K 0.01% 276
2023
Q4
$702K Buy
8,663
+569
+7% +$44.3K 0.02% 239
2023
Q3
$607K Buy
8,094
+72
+0.9% +$5.54K 0.02% 247
2023
Q2
$618K Sell
8,022
-915
-10% -$73K 0.02% 238
2023
Q1
$742K Buy
8,937
+802
+10% +$66.4K 0.03% 214
2022
Q4
$698K Sell
8,135
-172
-2% -$13.6K 0.03% 217
2022
Q3
$512K Buy
8,307
+1
+0% +$63 0.02% 234
2022
Q2
$513K Buy
8,306
+773
+10% +$47.9K 0.02% 236
2022
Q1
$448K Sell
7,533
-87
-1% -$5.56K 0.02% 184
2021
Q4
$553K Sell
7,620
-330
-4% -$22.7K 0.02% 166
2021
Q3
$555K Sell
7,950
-5
-0.1% -$351 0.03% 148
2021
Q2
$548K Sell
7,955
-50
-0.6% -$3.34K 0.03% 155
2021
Q1
$517K Sell
8,005
-800
-9% -$51.6K 0.03% 149
2020
Q4
$513K Buy
+8,805
New +$531K 0.03% 132

Other funds holding GILD

InterOcean Capital Group's GILD Position: Q1 2024 in Review

InterOcean Capital Group reduced its Gilead Sciences (GILD) stake by 5.6% in Q1 2024, selling an estimated $37.2K and leaving 8,179 shares worth $599K. The position accounts for 0.01% of the portfolio, ranked #276.

InterOcean Capital Group first reported a position in GILD in Q4 2020 and has held it in 14 quarters since. The position peaked at $742K in Q1 2023. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • InterOcean Capital Group held 8,179 shares of Gilead Sciences worth $599K as of Q1 2024.
  • InterOcean Capital Group sold 484 Gilead Sciences shares in Q1 2024, an estimated $37.2K.
  • Gilead Sciences made up 0.01% of InterOcean Capital Group's portfolio in Q1 2024, its #276 holding.
  • InterOcean Capital Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 14 quarters since.
  • InterOcean Capital Group's Gilead Sciences position peaked at $742K in Q1 2023.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.